Evaluation of Paeonia emodi for its cardioprotective potentials: An investigative study towards possible mechanism.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Paeonia emodi Wall. ex Royle (peony) is an important member of family Paeoniaceae. Different parts of the plant have been folklorically used for treatment of different diseases. Infusion of dried flowers is used to treat diarrhea, the seeds are emetic and cathartic while the rhizome has been indicated for the treatment of hysteria, abdominal spasm, nervine tonic and headache. Besides these, peony has also been used in different respiratory and cardiovascular diseases (CVDs) like hypertension, palpitations, congestive heart failure and atherosclerosis. Being a folkloric remedy for the treatment of CVDs, Paeonia emodi (P. emodi) requires to be explored scientifically for MI management.

AIM:

The current research work was designed to explore the possible cardioprotective mechanism of P. emodi in Isoproterenol hydrochloride (ISO) induced MI in mice.

MATERIALS AND METHODS:

Experimental animals randomly divided in different groups, received methanolic extract of P. emodi (Pe.ME) and its subsequent fractions for 15 days followed by ISO (100 mg/kg s.c) at 24 h interval for two days. The cardioprotective potential of the test samples were investigated by determining the serum levels of Alanine Amino Transferase (ALT), Aspartate Amino Transferase (AST), Lactate Dehydrogenase (LDH) and Creatine Phosphokinase (CPK). The ethyl acetate fraction (Pe.EA) was found potent among all the tested samples of P. emodi. Based on its high potency, Pe.EA was subjected to GC-MS analysis and further relevant experiments including anti-hyperlipidemic, antioxidant, lipid peroxidation, membrane stabilization, thrombolytic, DNA ladder assay and histopathological study.

RESULTS:

Pe.EA exhibited significant cardioprotective activity through reduction in levels of serum biomarkers responsible for MI. It significantly reduced serum levels of ALT (p < 0.001), AST (p < 0.001), CPK (p < 0.05) and LDH (p < 0.001) at a dose of 300 mg/kg as compared to ISO treated group. The GC-MS analysis confirmed the presence of potential compounds (esculetin, methyl eugenol, isovanillic acid) which might play a role in cardioprotection. Further screening confirmed that the effect of Pe.EA is mediated through multiple targets/mechanisms, which include anti-hyperlipidemia, antioxidant, lipid peroxidation inhibition, membrane stabilization, thrombolytic and DNA protective effects. Histopathological studies revealed the palliative effect for the damage caused in myocardial tissues.

CONCLUSION:

Findings of current study provide evidence that P. emodi is a potential candidate for the treatment and management of MI.

• Authors: Muhammad Ibrar, Mir Azam Khan, Abdullah, Mohammad Nisar, Munasib Khan
• Journal: Journal of ethnopharmacology (J Ethnopharmacol) Vol. 231 Pg. 57-65 (Mar 01 2019) ISSN: 1872-7573 [Electronic] Ireland
• PMID: 30391709 (Publication Type: Journal Article)
• Copyright: Copyright © 2018 Elsevier B.V. All rights reserved.

Chemical References

• Antioxidants
• Cardiotonic Agents
• Fibrinolytic Agents
• Hypolipidemic Agents
• Lipids
• Plant Extracts
• L-Lactate Dehydrogenase
• Aspartate Aminotransferases
• Alanine Transaminase
• Creatine Kinase
• Isoproterenol

Topics

• Alanine Transaminase (blood)
• Animals
• Antioxidants (pharmacology, therapeutic use)
• Aspartate Aminotransferases (blood)
• Cardiotonic Agents (pharmacology, therapeutic use)
• Creatine Kinase (blood)
• Female
• Fibrinolytic Agents (pharmacology, therapeutic use)
• Hypolipidemic Agents (pharmacology, therapeutic use)
• Isoproterenol
• L-Lactate Dehydrogenase (blood)
• Lipids (blood)
• Male
• Mice, Inbred BALB C
• Myocardial Infarction (blood, chemically induced, drug therapy, pathology)
• Myocardium (pathology)
• Paeonia
• Plant Extracts (pharmacology, therapeutic use)